RTRS - WILLIAM ACKMAN'S PERSHING SQUARE HOLDINGS HEDGE FUND ENDS 2015 WITH A 20.5 PERCENT LOSS- INVESTOR UPDATE
>>> Upgrades
>>> Downgrades
>>> Reiterations
>>> Initiations
GM reportedly looking at adopting Mobileye mapping technology - financial press
Sainsbury Made Approach to Home Retail, Offer Rejected
Sainsbury made approach to Home Retail in form of shares and cash in November.
* Sainsbury says combination is attractive proposition
* Has until Feb. 2 to make offer to Home Retail
* No certainty that there will be a formal offer
* Home retail share rise as much as 22%
RTRS - J SAINSBURY PLC SBRY.L - ?OVER LAST YEAR, CO HAS BEEN WORKING IN PARTNERSHIP WITH HOME RETAIL GROUP TRIALLING A NUMBER OF ARGOS CONCESSIONS IN CO'S STORES
Early premarket gappers
Gapping up: EXEL +9.3%, HMY +5.7%, SWHC +5.5%, CTIC +4.1%, RPRX +3.8%, BIN +3.4%, HIW +3.4%, FSLR +3.4%, VCEL +2.8%, BXLT +2%, FCX +1.7%, MT +1.5%, VALE +1.3%, SLV +1.1%, GDX +1.1%, ABX +1%, GG +1%
Gapping down: AKBA -4.5%, SDRL -3.7%, SYT -2.8%, ABB -2.7%, TOT -2.7%, RIG -2.7%, STO -2.6%, XLRN -2.3%, SAN -2.3%, PHG -2.3%, ASML -2.3%, LLY -2.3%, ERIC -2.2%, UN -1.9%, SAP -1.8%, BP -1.8%, DD -1.5%, BHP -1.5%, BCS -1.5%, RDS.A -1.4%, ING -1.4%, RCL -1.4%, DB -1.3%, DIS -1.2%, AZN -1%, HSBC -0.9%, COP -0.8%
Gapping down: AKBA -4.5%, SDRL -3.7%, SYT -2.8%, ABB -2.7%, TOT -2.7%, RIG -2.7%, STO -2.6%, XLRN -2.3%, SAN -2.3%, PHG -2.3%, ASML -2.3%, LLY -2.3%, ERIC -2.2%, UN -1.9%, SAP -1.8%, BP -1.8%, DD -1.5%, BHP -1.5%, BCS -1.5%, RDS.A -1.4%, ING -1.4%, RCL -1.4%, DB -1.3%, DIS -1.2%, AZN -1%, HSBC -0.9%, COP -0.8%
Eli Lilly follow-up: LLY reaffirms 2015 guidance, issues 2016 guidance below expectations
- Co reaffirms guidance for FY15 (Dec), sees EPS of $3.40-3.45 vs. $3.44 Capital IQ Consensus Estimate.
- Co issues downside guidance for FY16 (Dec), sees EPS of $3.45-3.55 vs. $3.64 Capital IQ Consensus Estimate; sees FY16 (Dec) revs of $20.2-20.7 bln vs. $21.33 bln Capital IQ Consensus Estimate. Non-GAAP figures for 2016 exclude amortization of intangibles as well as integration costs associated with the Novartis Animal Health acquisition.
- Excluding the unfavorable impact of foreign exchange rates, the company expects revenue growth from a number of established products including Humalog, Trajenta, Cialis, Forteo, Strattera, Erbitux, and animal health products, as well as higher revenues from new products including Cyramza, Trulicity, Jardianc, Portrazza, and Basaglar.
- "In 2016 we expect multiple regulatory actions across therapeutic areas including diabetes, oncology and immunology," said Derica Rice, Lilly's executive vice president for global services and chief financial officer.
Nothing really new just some precisions
In its 30-page complaint, the Justice Department said the charges carry fines of between $2,750 and $37,500 per car, per violation. Based on four separate violations laid out in the complaint, VW could theoretically face as much as $80 billion in penalties, which is higher than the $18 billion estimated when the scandal broke in September.
*AIR PRODUCTS CUT TO NEUTRAL VS BUY AT CITI, PT $143
*DUPONT CUT TO NEUTRAL VS BUY AT CITI, PT $70
*AGRIUM RAISED TO NEUTRAL VS SELL AT CITI, PT $91
*CELANESE RAISED TO BUY VS NEUTRAL AT CITI, PT $77
*EASTMAN CHEMICAL RAISED TO BUY VS NEUTRAL AT CITI, PT $75